Clinical Trials of Novel and Targeted Therapies: Endpoints, Trial Design, and Analysis

Author： Suman Vera Dueck Amylou Sargent Daniel

ISSN： 0735-7907

Source： Cancer Investigation, Vol.26, Iss.5, 2008-06, pp. : 439-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials of targeted toxins

By Frankel A.E. Tagge E.P. Willingham M.C.

Seminars in Cancer Biology, Vol. 6, Iss. 5, 1995-10 ,pp. : 307-317

Academic Press

Access to resources Recommend Favorite

Anti-angiogenic agents - clinical trial design and therapies in development

By Deplanque G. Harris A.L.

European Journal of Cancer, Vol. 36, Iss. 13, 2000-08 ,pp. : 1713-1724

Elsevier

Access to resources Recommend Favorite

Early oncology clinical trial design in the era of molecular-targeted agents

By Brunetto Andre T Kristeleit Rebecca S de Bono Johann S

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1339-1352

Future Medicine

Access to resources Recommend Favorite

Novel Targeted Therapies and Vaccination Strategies for Mesothelioma

By Bagia Mamta

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 149-162

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 661-665

Bentham Science Publishers

Access to resources Recommend Favorite